The changes of immune function after neuroblastoma chemotherapy and the prediction of potential immune targets
Abstract Background High-dose chemotherapy for neuroblastoma is often intolerable for children, and its effectiveness is difficult to determine. Immunotherapy has become a popular research focus as a potential treatment. Therefore, identifying effective immune targets and drug synergistic chemothera...
Saved in:
| Main Authors: | Yunfei Ma, Yan Su, Jing Huang, Wen Zhao, Cheng Huang, Jing Qin, Shengjie You, Yan Hu, Xin Ni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Medical Genomics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12920-025-02185-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metronomic chemotherapy in pediatric neuroblastoma
by: Yi Jiang, et al.
Published: (2024-12-01) -
Exosomes and immune modulation: implications for neuroblastoma immunotherapy
by: Martina Morini, et al.
Published: (2025-05-01) -
Neuroblastoma presenting as haemophagocytic lymphohistiocytosis
by: Monika Pogorzala
Published: (2025-04-01) -
Integrated bulk and single-cell RNA sequencing reveals a cuproptosis-related LncRNA prognostic signature in neuroblastoma
by: Ke Chen, et al.
Published: (2025-07-01) -
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
by: Hamed Alborzinia, et al.
Published: (2023-07-01)